Pumitamig plus docetaxel demonstrated encouraging responses in squamous and non-squamous non-small cell lung cancer across PD-L1 expression levels with a confirmed objective response rate of ...
Median overall survival of 15.9 months in Cyclin E1-positive PROC, with 1–5 prior lines of therapy; safety profile in DENALI ...
A California iPhone owner has taken Apple to court over claims the company oversold what its newest phones can actually do on Wi-Fi 7 networks. Terald Smith filed a proposed class action against Apple ...
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from ...
Get the live JPMorgan Fundamental Data Science Large Growth share price for the LGDS ETF, plus charts, technical analysis, historical data and the latest JPMorgan Fundamental Data Science Large Growth ...
Confirmed Objective Response Rate (ORR) and 29.2% Complete Response (CR) Rate in Final Phase 2 AnalysisMedian Overall Survival (OS) Not ...
View Frazier Life Sciences Acquisition Corp. II Class A FLSC stock quote prices, financial information, real-time forecasts, and company news from CNN.
Fundraising costs gobble up most of the funds raised. Billions are spent on TV ads that have virtually no impact. Candidates ...
This is the second year in a row that CPS’ graduation rate went up.
Immunovant's IMVT-1402 aims to deliver best-in-class FcRn inhibition, but mixed data tempers confidence in its superiority.
Wave Life Sciences' stock plummeted 58% in March 2026 after its obesity drug WVE-007 failed to show dose-dependent efficacy ...
Basel, 19 October 2026 - Roche (SIX: RO, ROP; OTCQX: RHHBY) will present new data, including two late-breaking abstracts, across lung, breast and other cancers at the 2026 European Society for Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results